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Sphingomonas 
mucosissima 
Bacteremia in 
Patient with Sickle 
Cell Disease 
To the Editor: The genus Sphin-
gomonas was proposed by Yabuuchi 
et al. in 1990 (1) and amended by 
Takeuchi et al. in 1993 (2). It now 
has been subdivided into 4 sepa-
rate genera: Sphingomonas sensu 
stricto,  Sphingobium,  Novosphingo-
bium, and Sphingopyxis. The bacteria 
of the genus Sphingomonas are yel-
low-pigmented, nonfermenting, gram-
negative bacilli with a single polar 
ﬂ  agellum; they are widely distributed 
in the natural environment, especially 
in water and soil (3). These bacteria 
are characterized by the presence of 
a unique sphingoglycolipid with the 
long-chain base—dihydrosphingosin, 
ubiquinone 10 (Q-10), and 2-hydrox-
ymyristic acid (2-OH C14:0)—and 
the absence of 3-hydroxy fatty ac-
ids (4). S. mucosissima was isolated 
and identiﬁ  ed in 2007 by Reddy and 
Garcia-Pichel from biologic soil crust 
samples collected from sandy arid 
soil in the US Colorado Plateau (5). 
Sphingomonas spp. are opportunis-
tic pathogens and have recently been 
implicated in a variety of community-
acquired and nosocomial infections, 
considered to originate from contami-
nated hospital equipment or manipu-
lation of some medical devices (3). 
The survival of Sphingomonas spp. in 
indoor dust particles as aerosols and 
their resistance to many disinfecting 
and toxic chemicals may explain their 
ability to colonize medical devices 
such as mechanical ventilators, cath-
eters, and bronchoﬁ  beroscopes (6). In 
the past few years, these organisms, in 
particular S. paucimobilis, have been 
implicated in a variety of community-
acquired and nosocomial infections. 
We report a case of S. mucosissima 
bacteremia in a patient with sickle cell 
disease. In February 2008, a 17-year-
old woman with homozygous sickle 
cell anemia was hospitalized when 
her condition suddenly became worse. 
The patient had undergone a splenec-
tomy in 1992 and a cholecystectomy in 
February 2007. Four days after admis-
sion, she had a fever of 38.7°C. Two 
aerobic blood specimens, drawn on the 
ﬁ  fth day of her hospitalization, yielded 
gram-negative bacilli after a 24-hour 
incubation. The gram-negative ba-
cilli were positive for catalase and 
oxidase but remained unidentiﬁ  ed by 
API 20NE strip (bioMérieux, Marcy 
l’Etoile, France). MICs of antimicro-
bial drugs were determined for the 
gram-negative bacilli by using an Etest 
assay (AB BIODISK, Solna, Sweden) 
on Mueller-Hinton medium. MICs 
were 1 μg/mL for cefotaxime, 1 μg/mL 
for amoxicillin–clavulanic acid, 2–3 
μg/mL for vancomycin, 0.064 μg/mL 
for imipenem, 4–5 μg/mL for ceftazi-
dime, 1 μg/mL for amikacin, 3 μg/mL 
for ciproﬂ  oxacin, and 0.047 μg/mL for 
trimethoprim-sulfamethoxazole.
DNA was extracted from 1 
colony by using a QIAamp Tissue 
kit (QIAGEN, Hilden, Germany) 
as described by the manufacturer. A 
16S rDNA sequence was obtained 
(1,410 bp) by using the fD1 (5′-
AGAGTTTGATCCTGGCTCAG-3′) 
and rP2 (5′-ACGGCTACCTTGTTAC
GACTT-3′) primer pair (7,8). Using 
BLAST version 2.2.9 software (www.
ncbi.nlm.nig.gov/BLAST), we de-
termined that this sequence showed 
98% similarity with the 16S rDNA se-
quence of S. mucosissima (GenBank 
accession no. AM229669). A phylo-
genetic neighbor-joining tree resulting 
from comparison of sequences of the 
16S rDNA genes of Sphingomonas 
spp. was made with the MEGA 3.1 
software (www.megasoftware.net). 
This analysis conﬁ  rmed that the iso-
late belonged to S. mucosissima. 
Initial treatment of intravenous 
administration of ceftriaxone was 
begun. The fever resolved after 1 
day and the patient’s condition im-
proved. Treatment was stopped af-
ter 5 days, and the patient remained 
apyretic. Two S. mucosissima iso-
lates were recovered from 2 differ-
ent blood-culture samples drawn 24 
hours apart, which suggests that S. 
mucosissima was not just a transient 
organism but indeed was responsible 
for the patient’s septicemia. Pheno-
typic identiﬁ  cation of the gram-neg-
ative bacilli failed because the deﬁ  -
nite bacterial species S. mucosissima 
was not included in the API database 
(http://industry.biomerieux-usa.com/
industry/food/api/apiweb.htm) used 
for the phenotypic identiﬁ  cation. 
However, the isolates’ biochemical 
characteristics were consistent with 
those previously reported for S. mu-
cosissima ( 5) (Table). Final identi-
ﬁ  cation was achieved by comparing 
the almost complete 16S rDNA se-
quence with homologous sequences 
deposited in GenBank.
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Table. Biochemical characteristics of the previously reported Sphingomonas 
mucosissima isolate (AM229669) and the isolate from this study 
Characteristic S. mucosissima Isolate from this study 
Biochemical characteristics 
 Oxidase  + +
 Catalase  + +
 Phosphatase  + +
  ȕ-galactosidase ––
 Gelatinase  – –
 Nitrate  reduction  – –
Assimilation of carbon compounds 
 Alanine  + +
 Glucose  + +
 Glutamic  acid  – –
 Mannitol  – –
 Sucrose  + +LETTERS
We believe that the patient’s in-
travenous catheter was the source of 
the infection because she did not have 
wound infections, and cultures of her 
urine were negative for infectious 
agents. Antimicrobial drug treatment, 
selected on the basis of an in vitro S. 
mucosissima susceptibility proﬁ  le, fa-
cilitated the patient’s recovery. This 
case report illustrates that the patho-
genic potential of S. mucosissima 
should be considered in diagnosis in 
such cases because the organism can 
cause bacteremia in patients, primarily 
in those with underlying debilitating 
conditions and those who have under-
gone medical interventions.
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WU Polyomavirus in 
Fecal Specimens of 
Children with Acute 
Gastroenteritis, 
China 
To the Editor: WU polyomavi-
rus (WUPyV) is a recently described 
PyV found in patients with acute re-
spiratory tract infections (1). The role 
of the virus in disease pathogenesis 
remains unclear. The ability to detect 
it in clinical specimens would help 
in the determination of its replication 
sites and its routes of transmission 
and dissemination. WUPyV has been 
found in specimens from the respira-
tory tract only (1).
Previous studies of other PyVs, 
including BK virus, JC virus, and the 
newly identiﬁ  ed KIPyV, demonstrat-
ed their presence in fecal specimens 
(2,3), which suggests their potential 
for transmission through the gas-
trointestinal (GI) tract (2). Because 
some children (6.8%–27.7%) who 
had WUPyV results in previous stud-
ies (1,4,5) displayed respiratory and 
GI clinical signs, we speculated that 
WUPyV might also be transmitted 
through the GI tract.
In this study, we tested for the pres-
ence of WUPyV in children with acute 
gastroenteritis. A total of 377 fecal 
specimens were collected from children 
with acute nonbacterial gastroenteritis 
at the Outpatient Clinic Department of 
the Beijing Children’s Hospital from 
March 2006 through November 2007. 
Patients with nonbacterial gastroen-
teritis were deﬁ   ned as 1) those who 
had acute, watery, but not bloody, di-
arrhea, accompanied by other clinical 
signs and symptoms such as fever, ab-
dominal cramps, nausea, vomiting, and 
headache; and 2) those who had nega-
tive test results for any known bacteria 
that might cause gastroenteritis, such as 
Salmonella spp., Shigella spp., Staphy-
lococcus spp., Campylobacter jejuni, 
Clostridium spp., Escherichia coli, and 
Yersinia spp.
All patients, whose ages ranged 
from 1 month to 13 years (mean age 
11.7 months, median age 9 months), did 
not exhibit apparent clinical respirato-
ry signs. Fecal specimens from patients 
were diluted in phosphate-buffered sa-
line (pH 7.2) by using a 10% wt/vol 
ratio and were cleared of cell debris by 
centrifugation (2,500 × g, 5 min). Virus 
nucleic acids were extracted by using 
the NucliSens miniMAG and isolation 
reagents according to the manufactur-
er’s instructions (bioMérieux, Marcy 
l’Etoile, France). Samples were subse-
quently screened for group A rotavirus 
(RVA) by using the rotavirus ELISA 
diagnostic kit (Lanzhou Institute for 
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